Sangamo Therapeutics Inc (NASDAQ:SGMO)

10.66
Delayed Data
As of Sep 20
 +0.03 / +0.28%
Today’s Change
6.26
Today|||52-Week Range
17.35
-7.14%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close10.63
Today’s open10.60
Day’s range10.50 - 10.97
Volume2,179,078
Average volume (3 months)1,564,341
Market cap$1.2B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-0.70%
Earnings growth (this year)-94.46%
Earnings growth (next 5 years)-17.98%
Revenue growth (last year)+130.95%
P/E ratioNM
Price/Sales13.18
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
EDITEditas Medicine Inc-0.19-0.75%
RDUSRadius Health Inc-0.39-1.35%
MNTAMomenta Pharmaceutic...+0.06+0.45%
ANABAnaptysBio Inc-0.54-1.29%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$84.5M
Annual profit (last year)-$68.3M
Net profit margin-80.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander D. Macrae
Chief Financial Officer, EVP-
Corporate Strategy
Stéphane Boissel
Corporate headquarters
Richmond, California

Forecasts